You are not currently logged in.
Access JSTOR through your library or other institution:
Iontophoresis of Vidarabine Monophosphate for Herpes Orolabialis
Louis P. Gangarosa Sr., James M. Hill, Barry L. Thompson, Carol Leggett and J. Peter Rissing
The Journal of Infectious Diseases
Vol. 154, No. 6 (Dec., 1986), pp. 930-934
Published by: Oxford University Press
Stable URL: http://www.jstor.org/stable/30104975
Page Count: 5
You can always find the topics here!Topics: Lesions, Viruses, Antivirals, Infections, Simplexvirus, Placebos, Statistical significance, Microelectromechanical systems, Cotton, Plaque assay
Were these topics helpful?See something inaccurate? Let us know!
Select the topics that are inaccurate.
Preview not available
The cutaneous application of antiviral agents was studied by iontophoresis, a process that increases penetration of most drugs 20 to 60-fold. Twenty-seven subjects with vesicular orolabial herpes were treated one time in a double-blind, placebo-controlled clinical study: nine received vidarabine monophosphate (ara-AMP), nine received acyclovir (ACV), and nine received NaCl. Ara-AMP-treated lesions yielded lower titers of virus after 24 hr compared with lesions treated with NaCl or ACV (P< .05). Ara-AMP significantly decreased the duration of shedding of virus (P < .05) and time to dry crust (P < .05) compared with the other two agents. There was a trend toward decreased healing time after ara-AMP treatment.
The Journal of Infectious Diseases © 1986 Oxford University Press